Ionizable cationic lipids
US-2024383841-A1 · Nov 21, 2024 · US
US9687531B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9687531-B2 |
| Application number | US-201414463955-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 20, 2014 |
| Priority date | Jan 18, 2001 |
| Publication date | Jun 27, 2017 |
| Grant date | Jun 27, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods to introduce highly phosphorylated mannopyranosyl oligosaccharide derivatives containing mannose-6-phosphate (M6P), or other oligosaccharides bearing other terminal hexoses, to carbonyl groups on oxidized glycans of glycoproteins while retaining their biological activity are described. The methods are useful for modifying glycoproteins, including those produced by recombinant protein expression systems, to increase uptake by cell surface receptor-mediated mechanisms, thus improving their therapeutic efficacy in a variety of applications.
Opening claim text (preview).
What is claimed is: 1. A method of coupling a beta-glucocerebrosidase to an oligosaccharide that comprises a phosphorylated mannose, comprising: (a) derivatizing an oligosaccharide comprising a phosphorylated mannose with a compound containing a carbonyl-reactive group; (b) oxidizing a beta-glucocerebrosidase having at least one oligosaccharide to generate at least one carbonyl group on the at least one oligosaccharide of the beta-glucocerebrosidase; and (c) reacting the derivatized oligosaccharide with the oxidized beta-glucocerebrosidase, thereby coupling the oligosaccharide to the beta-glucocerebrosidase. 2. The method of claim 1 , wherein the oligosaccharide is a biantennary mannopyranosyl oligosaccharide. 3. The method of claim 2 , wherein the biantennary mannopyranosyl oligosaccharide comprises bis-mannose 6 phosphate (M6P). 4. The method of claim 1 , wherein the carbonyl-reactive group is a hydrazine, a hydrazide, an aminooxy, or a semicarbazide. 5. The method of claim 1 , wherein periodate or galactose oxidase is used to oxidize the beta-glucocerebrosidase. 6. The method of claim 5 , wherein less than or equal to about 10mM periodate is used to oxidize one or more sialic acid residues on the beta-glucocerebrosidase. 7. A conjugate comprising a beta-glucocerebrosidase coupled to an oligosaccharide comprising a phosphorylated mannose, prepared by the method of claim 1 . 8. A method of treating Gaucher disease, comprising administering to a subject in need thereof the conjugate of claim 7 . 9. The method of claim 8 , wherein the oligosaccharide is a biantennary mannopyranosyl oligosaccharide. 10. The method according to claim 9 , wherein the biantennary mannopyranosyl oligosaccharide comprises bis-M6P. 11. The method of claim 8 , wherein the oxidizing is by contact with periodate or galactose oxidase. 12. The method of claim 8 , wherein the carbonyl-reactive group is a hydrazine, a hydrazide, an aminooxy, or a semicarbazide. 13. A method of coupling a beta-N-acetyl-hexosaminidase to an oligosaccharide that comprises a phosphorylated mannose, comprising: (a) derivatizing an oligosaccharide comprising a phosphorylated mannose with a compound containing a carbonyl-reactive group; (b) oxidizing a beta-N-acetyl-hexosaminidase having at least one oligosaccharide to generate at least one carbonyl group on the at least one oligosaccharide of the beta-N-acetyl-hexosaminidase; and (c) reacting the derivatized oligosaccharide with the oxidized beta-N-acetyl-hexosaminidase, thereby coupling the oligosaccharide to the beta-N-acetyl-hexosaminidase. 14. The method of claim 13 , wherein the oligosaccharide is a biantennary mannopyranosyl oligosaccharide. 15. The method of claim 14 , wherein the biantennary mannopyranosyl oligosaccharide comprises bis-mannose 6 phosphate (M6P). 16. The method of claim 13 , wherein the carbonyl-reactive group is a hydrazine, a hydrazide, an aminooxy, or a semicarbazide. 17. The method of claim 13 , wherein periodate or galactose oxidase is used to oxidize the beta-N-acetyl-hexosaminidase. 18. The method of claim 17 , wherein less than or equal to about 10 mM periodate is used to oxidize one or more sialic acid residues on the beta-N-acetyl-hexosaminidase. 19. A conjugate comprising a beta-N-acetyl-hexosaminidase coupled to an oligosaccharide comprising a phosphorylated mannose, prepared by the method of claim 13 . 20. A method of treating Tay-Sachs disease, comprising administering to a subject in need thereof the conjugate of claim 19 . 21. The method of claim 20 , wherein the oligosaccharide is a biantennary mannopyranosyl oligosaccharide. 22. The method according to claim 21 , wherein the biantennary mannopyranosyl oligosaccharide comprises bis-M6P. 23. The method of claim 20 , wherein the oxidizing is by contact with periodate or galactose oxidase. 24. The method of claim 20 , wherein the carbonyl-reactive group is a hydrazine, a hydrazide, an aminooxy, or a semicarbazide.
acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22) · CPC title
Glycopeptides, glycoproteins · CPC title
from mammals · CPC title
by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids · CPC title
Phosphates; Phosphites; Polyphosphates · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.